Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Sales | 254,733 | 259,871 | 184,403 | 392,218 | 227,909 |
| Cost of Goods | 119,720 | 136,138 | 159,512 | -195,089 | 393,335 |
| Gross Profit | 135,013 | 123,733 | 24,891 | 587,307 | -165,426 |
| Operating Expenses | 56,980 | 79,268 | 77,207 | 72,061 | 107,537 |
| Operating Income | 78,753 | 44,603 | -51,804 | 515,157 | -272,628 |
| Interest Expense | 19,218 | 17,726 | 13,226 | 27,409 | 11,089 |
| Other Income | -33,151 | 12,723 | -2,500 | 32,385 | -151 |
| Pre-tax Income | 26,384 | 39,600 | -67,530 | 520,133 | -283,868 |
| Income Tax | -738 | 1,852 | 30,901 | 118,261 | -104,531 |
| Net Income Continuous | 27,122 | 37,748 | -98,431 | 401,872 | -179,337 |
| Minority Interests | 342 | 302 | N/A | N/A | N/A |
| Net Income | $26,780 | $37,446 | $-98,431 | $399,824 | $-179,337 |
| EPS Basic Total Ops | N/A | N/A | -1.37 | N/A | -2.51 |
| EPS Basic Continuous Ops | N/A | N/A | -1.37 | N/A | -2.51 |
| EPS Diluted Total Ops | N/A | N/A | -1.37 | N/A | -2.51 |
| EPS Diluted Continuous Ops | N/A | N/A | -1.37 | N/A | -2.51 |
| EBITDA(a) | $92,143 | $42,451 | $-26,053 | $488,127 | $-245,946 |